Related Experiment Video
Updated: Jun 10, 2025

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Trends and Prospects of Low-Density Lipoprotein Cholesterol in Stroke: A Bibliometric Analysis
Bofeng Yang1, Xianjun Ma1, Li Yang2
1Department of Neurology, Lianyungang Affiliated Hospital of Nanjing University of Chinese Medicine, Lianyungang, CHN.
Insights
Managing low-density lipoprotein cholesterol (LDL-C) after stroke focuses on pharmacological treatments. Future research trends include novel lipid-lowering therapies and advanced analytical techniques for cardiovascular disease care.
Area of Science:
- Cardiology and Neurology
- Bibliometrics and Research Trends
Background:
- Effective management of low-density lipoprotein cholesterol (LDL-C) is vital in stroke care and cardiovascular disease prevention.
- Recent advancements have improved understanding and treatment strategies for LDL-C in stroke patients.
Purpose of the Study:
- To analyze bibliometric trends in LDL-C management research in stroke over the past decade.
- To identify key research topics, influential publications, and collaboration patterns.
Main Methods:
- Bibliometric analysis of 2,841 publications from the Web of Science database.
- Trend topic analysis, co-authorship analysis, and co-citation analysis were employed.
Main Results:
- Research predominantly focused on epidemiological studies and pharmacological management strategies.
- Key journals identified include The New England Journal of Medicine, Circulation, and Atherosclerosis.
- Strong international collaboration exists between the USA and England, and USA and China, though institutional collaboration needs strengthening.
Conclusions:
- Future research will likely explore advanced lipid-lowering therapies, including statins and PCSK9 inhibitors.
- Assessing residual cholesterol and utilizing Mendelian randomization are potential future research directions.
- Enhanced international institutional collaboration, particularly between the USA and China, is recommended to advance the field.
Abstract:
Management of low-density lipoprotein cholesterol (LDL-C) in stroke is a crucial component of cardiovascular disease care. Recent years have seen substantial progress in understanding and managing LDL-C in the context of stroke. This study utilized bibliometric methods to analyze and synthesize trends in this area over the past decade, incorporating 2,841 publications from the Web of Science database. The analyses included trend topic analysis, co-authorship analysis, and co-citation analysis. The findings indicate that research had predominantly concentrated on epidemiological studies related to pharmacological management strategies. Future research is expected to continue exploring lipid-lowering therapies, including both established treatments like statins and newer drugs such as proprotein convertase subtilisin-kexin type 9 inhibitors. Assessing residual cholesterol and employing Mendelian randomization techniques may become potential research hotspots. The New England Journal of Medicine is the most globally influential journal, while Circulation holds the most influence within the field, and Atherosclerosis ranks as the most prolific. International collaboration in this research area was strong between the USA and England, followed by the USA and China. However, collaboration between productive institutions in the USA and China remains limited, highlighting the need to strengthen partnerships between these institutions to further advance the field.
Related Concept Videos
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Atherosclerosis III: Management
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Coronary Artery Disease IV: Medical Management
Cholesterol: Significance and Regulation
Considering cholesterol and...
Lipids: Dietary Sources and Requirements

